Home

>

Stocks

>

Apollo Hospitals Enterprise Limited

info-icon
The current prices are delayed, login to your account for live prices
Login

Apollo Hospitals Enterprise Limited

APOLLOHOSP

BSE
NSE

Healthcare / Hospitals

Loading...

NSE / BSE

About

Apollo Hospitals Enterprise Limited

Company Overview

Apollo Hospitals Enterprise Limited stands as Asia's foremost integrated healthcare services provider and the first corporate hospital in India. Established in 1983 by Dr. Prathap C Reddy, renowned architect of modern healthcare in India, the company has been acclaimed for pioneering the private healthcare revolution in the country.

Business Overview and Operations

Apollo Hospitals has emerged as Asia's foremost integrated healthcare services provider and has a robust presence across the healthcare ecosystem, including Hospitals, Pharmacies, Primary Care & Diagnostic Clinics and several Retail Health models. The company operates through four key segments: Healthcare Services, Retail Health & Diagnostics, Digital Health & Pharmacy Distribution, and Others.

The healthcare giant maintains an impressive infrastructure with a capacity of 10,134 beds in 73 hospitals located in India and overseas, out of which 8,709 beds are located in 45 owned hospitals, 639 beds in Day Surgery & Cradles and 790 beds are in 6 hospitals under management through operations and management contracts. The company's hospitals are strategically located across major cities including Chennai, Hyderabad, Delhi, Ahmedabad, Pune, and other metropolitan areas.

Financial Performance and Market Position

As of the latest available data, Apollo Hospitals has a market capitalization of ₹1,08,608 crore, reflecting its dominant position in the healthcare sector. The company demonstrated strong financial performance in FY25, with consolidated net profit of ₹1,445.9 crore for FY25, up 60.91 per cent from ₹898.6 crore in FY24, while revenue for FY25 stood at ₹21,794 crore, compared to ₹19,059.2 crore recorded in FY24.

The fourth quarter of FY25 showcased particularly impressive results, with consolidated profit after tax at ₹389.6 crore for the quarter ended 31 March 2025, up from ₹253.8 crore in the year-ago period. Quarterly revenue performance was equally strong, with revenue from operations in Q4 FY25 stood at ₹5,592.2 crore, up around 13.11 per cent from ₹4,943.9 crore in Q4 FY24.

Key financial metrics as of March 2025:

- Revenue: ₹21,794 crore (FY25)

- Net Profit: ₹1,445.9 crore (FY25)

- Q4 FY25 Revenue: ₹5,592.2 crore

- Q4 FY25 Net Profit: ₹389.6 crore

- EBITDA: ₹3,022 crore (FY25), up 26% YoY

Expansion and Growth Strategy

Apollo Hospitals continues to pursue aggressive expansion plans to strengthen its market position. The company plans to invest ₹8,000 crore to expand its healthcare ecosystem, maintaining a positive outlook for FY26. The expansion strategy includes adding 4,300 beds to its existing capacity, with new facilities planned across multiple cities.

Larsen & Toubro's Buildings & Factories vertical plans to enter contracts worth ₹2,400 crore to construct hospital buildings for Apollo Hospitals across India, highlighting the scale of the company's infrastructure development initiatives.

Digital Health and Technology Integration

The company has made significant strides in digital healthcare through its Apollo 24/7 platform. Apollo 24/7 has over 40 million registered users and is projected to reach 1 million daily users by September. The digital health segment has shown promising growth, with ₹9,093 crore in revenue for FY25, with profitability achieved over three consecutive quarters.

The company expects its digital healthcare arm to breakeven by FY26, demonstrating the potential of its technology-driven healthcare solutions.

Shareholding Structure and Corporate Governance

The company maintains a stable ownership structure with promoter holding at 29.3% as of the latest available data. Promoter holding in Apollo Hospitals Enterprise Ltd has gone up to 29.34 per cent as of Mar 2025 from 29.33 per cent as of Jun 2024, indicating consistency in promoter commitment.

Strategic Initiatives and Future Outlook

Apollo Hospitals has announced several strategic initiatives to enhance its business portfolio. Apollo Hospitals announces composite scheme merging Keimed, creating INR 16,267 Cr revenue NewCo by FY25. Additionally, Apollo Hospitals Enterprise Ltd. announced the spin-off of its digital health and pharmacy businesses into a new entity, NewCo, expected to list within 18-21 months.

The company's business segments are well-diversified, with Healthcare Services representing 52% in H1 FY25, providing stability and growth opportunities across multiple revenue streams. The healthcare services division continues to be the primary revenue contributor, benefiting from increased patient volumes and operational efficiencies.

Apollo Hospitals' commitment to excellence in healthcare delivery, combined with its robust financial performance and strategic expansion plans, positions it as a leading investment opportunity in India's rapidly growing healthcare sector. The company's focus on integrating technology with traditional healthcare services and its nationwide presence make it well-positioned to capitalize on the increasing demand for quality healthcare in India.